Donor Variation and Optimization of Human Mesenchymal Stem Cell Chondrogenesis in Hyaluronic Acid.

Mesenchymal stem cells (MSCs) are an attractive cell type for cartilage repair that can undergo chondrogenesis in a variety of three-dimensional (3D) scaffolds. Hyaluronic acid (HA) hydrogels provide a biologically relevant interface for cell encapsulation. While previous studies have shown that MSC-laden HA constructs can mature in vitro to match native mechanical properties using cells from animal sources, clinical application will depend on the successful translation of these findings to human cells. Though numerous studies have investigated chondrogenesis of human MSC (hMSC)-laden constructs, their functional outcomes were quite inferior to those using animal sources, and donor-specific responses to 3D HA hydrogels have not been fully investigated. To that end, hMSCs were derived from seven donors, and their ability to undergo chondrogenesis in pellet culture and HA hydrogels was evaluated. Given the initial observation of overt cell aggregation and/or gel contraction for some donors, the impact of variation in cell and HA macromer concentration on functional outcomes during chondrogenesis was evaluated using one young/healthy donor. The findings show marked differences in functional chondrogenesis of hMSCs in 3D HA hydrogels based on donor. Increasing cell density resulted in increased mechanical properties, but also promoted construct contraction. Increasing the macromer density generally stabilized construct dimensions and increased extracellular matrix production, but limited the distribution of formed matrix at the center of the construct and reduced mechanical properties. Collectively, these findings suggest that the use of hMSCs may require tuning of cell density and gel mechanics on a donor-by-donor basis to provide for the most robust tissue formation for clinical application.

[1]  D. Steinberg,et al.  Role of dexamethasone in the long‐term functional maturation of MSC‐laden hyaluronic acid hydrogels for cartilage tissue engineering , 2018, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  J. Burdick,et al.  Dose and Timing of N‐Cadherin Mimetic Peptides Regulate MSC Chondrogenesis within Hydrogels , 2018, Advanced healthcare materials.

[3]  D. Agrawal,et al.  Recent strategies in cartilage repair: A systemic review of the scaffold development and tissue engineering. , 2017, Journal of biomedical materials research. Part A.

[4]  D. Steinberg,et al.  Enhanced nutrient transport improves the depth-dependent properties of tri-layered engineered cartilage constructs with zonal co-culture of chondrocytes and MSCs. , 2017, Acta biomaterialia.

[5]  J A Burdick,et al.  Recent advances in hydrogels for cartilage tissue engineering. , 2017, European cells & materials.

[6]  A. Fakhari,et al.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. , 2013, Acta biomaterialia.

[7]  C. V. van Blitterswijk,et al.  The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. , 2013, Tissue engineering. Part A.

[8]  L. Bian,et al.  Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis , 2013, Proceedings of the National Academy of Sciences.

[9]  Farshid Guilak,et al.  Tissue engineering for articular cartilage repair--the state of the art. , 2013, European cells & materials.

[10]  Jason A Burdick,et al.  High mesenchymal stem cell seeding densities in hyaluronic acid hydrogels produce engineered cartilage with native tissue properties. , 2012, Acta biomaterialia.

[11]  Jason A Burdick,et al.  Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid. , 2011, Biomaterials.

[12]  E. Hunziker,et al.  Differential effects of dexamethasone on the chondrogenesis of mesenchymal stromal cells: influence of microenvironment, tissue origin and growth factor. , 2011, European cells & materials.

[13]  I. Erickson,et al.  Cartilage Matrix Formation by Bovine Mesenchymal Stem Cells in Three-dimensional Culture Is Age-dependent , 2011, Clinical orthopaedics and related research.

[14]  Liming Bian,et al.  Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. , 2011, Tissue engineering. Part A.

[15]  K. Kaibuchi,et al.  Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity , 2010, Cytoskeleton.

[16]  J. Burdick,et al.  Macromer density influences mesenchymal stem cell chondrogenesis and maturation in photocrosslinked hyaluronic acid hydrogels. , 2009, Osteoarthritis and cartilage.

[17]  C. Chu,et al.  Donor sex and age influence the chondrogenic potential of human femoral bone marrow stem cells. , 2009, Osteoarthritis and cartilage.

[18]  J. Burdick,et al.  Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. , 2009, Tissue engineering. Part A.

[19]  H. Im,et al.  Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis. , 2009, Arthritis and rheumatism.

[20]  B. A. Byers,et al.  Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. , 2008, Tissue engineering. Part A.

[21]  R. Stoop,et al.  Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology , 2007, Stem cells.

[22]  C. V. van Blitterswijk,et al.  The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. , 2007, Current stem cell research & therapy.

[23]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  K. Anseth,et al.  Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks. , 2007, Tissue engineering.

[25]  D. Saris,et al.  Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic joints. , 2006, Osteoarthritis and cartilage.

[26]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Sox9 Expression and Actin Organization during Chondrogenesis* , 2005, Journal of Biological Chemistry.

[27]  Kenneth Dixon,et al.  Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. , 2002, Arthritis and rheumatism.

[28]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[29]  G A Ateshian,et al.  Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. , 2000, Journal of biomechanical engineering.

[30]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[31]  G A Ateshian,et al.  Experimental verification and theoretical prediction of cartilage interstitial fluid pressurization at an impermeable contact interface in confined compression. , 1998, Journal of biomechanics.

[32]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[33]  J. Pelletier,et al.  Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. , 1994, Arthritis and rheumatism.

[34]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[35]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[36]  R. E. Neuman,et al.  The determination of hydroxyproline. , 1950, The Journal of biological chemistry.

[37]  S. Varghese,et al.  Osteoarthritic chondrocyte-secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. , 2011, Arthritis and rheumatism.

[38]  Robert Langer,et al.  Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. , 2005, Biomacromolecules.

[39]  G A Ateshian,et al.  Mechanical response of bovine articular cartilage under dynamic unconfined compression loading at physiological stress levels. , 2004, Osteoarthritis and cartilage.

[40]  R. Loeser,et al.  CD44 and integrin matrix receptors participate in cartilage homeostasis , 2002, Cellular and Molecular Life Sciences CMLS.

[41]  A M Mackay,et al.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. , 1998, Tissue engineering.

[42]  J. Vacanti,et al.  Tissue engineering. , 1993, Science.